U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H29FO5
Molecular Weight 392.4611
Optical Activity UNSPECIFIED
Defined Stereocenters 8 / 8
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DEXAMETHASONE

SMILES

[H][C@@]12C[C@@H](C)[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]3(F)[C@@]2([H])CCC4=CC(=O)C=C[C@]34C

InChI

InChIKey=UREBDLICKHMUKA-CXSFZGCWSA-N
InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1

HIDE SMILES / InChI
Molecular Formula C22H29FO5
Molecular Weight 392.4611
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 8 / 8
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Unknown
86413
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:09:21 UTC 2023
Edited
by admin
on Fri Dec 15 15:09:21 UTC 2023
Record UNII
7S5I7G3JQL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DEXAMETHASONE
EMA EPAR   EP   GREEN BOOK   HSDB   INN   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INN  
Official Name English
ISV-305
Code English
DEXASONE
Brand Name English
DEXAMETHASONE [MART.]
Common Name English
DEXAMETHASONE [EP MONOGRAPH]
Common Name English
DEXAMETHASONE COMPONENT OF TOBRADEX ST
Brand Name English
DEXAMETHASONE [ORANGE BOOK]
Common Name English
DEXAMETHASONE COMPONENT OF CIPRODEX
Brand Name English
DEXAMETHASONE [USP-RS]
Common Name English
LOVERINE
Brand Name English
GAMMACORTEN
Common Name English
DEXAMETASONE
Common Name English
Dexamethasone [WHO-DD]
Common Name English
MAXIDEX
Brand Name English
SUPERPREDNOL
Common Name English
DEXAMETHASONE ACETATE IMPURITY A [EP IMPURITY]
Common Name English
FORTECORTIN
Brand Name English
DEXASPORIN COMPONENT DEXAMETHASONE
Brand Name English
BETAMETHASONE IMPURITY A [EP IMPURITY]
Common Name English
DEXAMETHASONE [JAN]
Common Name English
(11.BETA.,16.ALPHA.)-9-FLUORO-11,17,21-TRIHYDROXY-16-METHYLPREGNA-1,4-DIENE-3,20-DIONE
Systematic Name English
DEXA-SINE
Brand Name English
DEXONE
Brand Name English
MAXITROL COMPONENT DEXAMETHASONE
Brand Name English
DEXAMETHASONUM [WHO-IP LATIN]
Common Name English
DEXAMETHASONE COMPONENT OF DEXASPORIN
Brand Name English
NSC-34521
Code English
DEXAMETHASONE [EMA EPAR]
Common Name English
FLUORMETHYLPREDNISOLONE
Common Name English
AEROSEB-DEX
Brand Name English
dexamethasone [INN]
Common Name English
DEXAMETHASONE COMPONENT OF DEXACIDIN
Brand Name English
DEXASITE
Brand Name English
DEXAMONOZON
Brand Name English
DEXAMETHASONE COMPONENT OF TOBRADEX
Brand Name English
DEXAMETHASONE [VANDF]
Common Name English
DEXAPOS
Brand Name English
LUXAZONE
Brand Name English
DECADRON
Brand Name English
DEXYCU
Brand Name English
TOBRADEX ST COMPONENT DEXAMETHASONE
Brand Name English
PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,17,21-TRIHYDROXY-16-METHYL-,(11.BETA.,16.ALPHA.)-9-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.ALPHA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE
Common Name English
DEXACIDIN COMPONENT DEXAMETHASONE
Brand Name English
DEXAMETHASONE [WHO-IP]
Common Name English
TOBRADEX COMPONENT DEXAMETHASONE
Brand Name English
HEMADY
Brand Name English
HEXADROL
Brand Name English
DECADERM
Brand Name English
DEXAMETHASONE [USP MONOGRAPH]
Common Name English
OZURDEX
Brand Name English
ISOPTO-DEX
Brand Name English
CIPRODEX COMPONENT DEXAMETHASONE
Brand Name English
DEXAMETHASONE [HSDB]
Common Name English
DEXAMETHASONE [MI]
Common Name English
VISUMETAZONE
Common Name English
HEXADECADROL
Common Name English
DEXACORTAL
Brand Name English
9-Fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione
Systematic Name English
DECASPRAY
Brand Name English
MILLICORTEN
Common Name English
DEXACORTIN
Brand Name English
DEXAMETHASONE COMPONENT OF MAXITROL
Brand Name English
DEXTENZA
Brand Name English
16.ALPHA.-METHYL-9.ALPHA.-FLUOROPREDNISOLONE
Common Name English
APHTHASOLONE
Common Name English
OTO-104
Code English
DEXAMETHASONE [GREEN BOOK]
Common Name English
Classification Tree Code System Code
WHO-ATC R01AD03
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 8.4
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 522.540
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 520.540
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 520.540A
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QD10AA03
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
FDA ORPHAN DRUG 674718
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC S01BA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC S03BA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC D07XB05
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QR01AD03
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QD07AB19
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QH02AB02
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 17.2
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
NCI_THESAURUS C521
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
FDA ORPHAN DRUG 795620
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
NDF-RT N0000175576
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QS01CB01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QD07XB05
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC C05AA09
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 520.540C
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC R01AD53
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
EMA ASSESSMENT REPORTS OZURDEX (AUTHORIZED: MACULAR EDEMA)
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QS02BA06
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
EMA ASSESSMENT REPORTS ORZUDEX (AUTHORIZED: UVEITIS)
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QD07CB04
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC S03CA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC S02BA06
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QS03CA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC S01CA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
FDA ORPHAN DRUG 626318
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QS01BA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
FDA ORPHAN DRUG 115298
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC S02CA06
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QR01AD53
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 8.3
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
LIVERTOX 288
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 522.542
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
NCI_THESAURUS C267
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QS03BA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC D07AB19
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QS01CA01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QC05AA09
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
NDF-RT N0000175450
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC S01CB01
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
EMA ASSESSMENT REPORTS NEOFORDEX (AUTHORIZED: MULTIPLE MYELOMA)
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC H02AB02
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QA01AC02
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 520.540B
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC A01AC02
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC D10AA03
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ESSENTIAL MEDICINES LIST 03
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
EU-Orphan Drug EU/3/10/763
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 524.1484G
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QH02BX90
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
CFR 21 CFR 520.563
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-ATC D07CB04
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
WHO-VATC QS02CA06
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
Code System Code Type Description
WIKIPEDIA
DEXAMETHASONE
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
NSC
34521
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
PUBCHEM
5743
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
NCI_THESAURUS
C422
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
DAILYMED
7S5I7G3JQL
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
LACTMED
Dexamethasone, Topical
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
HSDB
3053
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
MERCK INDEX
m4215
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY Merck Index
RXCUI
3264
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY RxNorm
DRUG BANK
DB01234
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
CHEBI
32132
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
DEXAMETHASONE
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY Description: Colourless crystals or a white or almost white, crystalline powder; odourless. Solubility: Practically insoluble in water; sparingly soluble in ethanol (~750 g/l) TS.Category: Adrenoglucocorticoid. Storage: Dexamethasone should be kept in a tightly closed container, protected from light.
CHEBI
41879
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
LACTMED
Dexamethasone
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
DRUG CENTRAL
824
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
RS_ITEM_NUM
1176007
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
FDA UNII
7S5I7G3JQL
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
MESH
D003907
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
IUPHAR
2768
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
EPA CompTox
DTXSID3020384
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
ECHA (EC/EINECS)
200-003-9
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
EVMPD
SUB07017MIG
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
CAS
50-02-2
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
ChEMBL
CHEMBL384467
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
INN
816
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
SMS_ID
100000092605
Created by admin on Fri Dec 15 15:09:21 UTC 2023 , Edited by admin on Fri Dec 15 15:09:21 UTC 2023
PRIMARY
Related Record Type Details
GLUCOCORTICOID RECEPTOR
TARGET -> INHIBITOR
BINDING
IC50
CYTOCHROME P450 2A6
METABOLIC ENZYME -> INDUCER
CYTOCHROME P450 3A5
METABOLIC ENZYME -> INDUCER
Structure of Dexamethasone H-3
LABELED -> NON-LABELED
GLUCOCORTICOID RECEPTOR
TARGET -> AGONIST
BINDING
URIDINE DIPHOSPHATE GLUCURONOSYLTRANSFERASE 2B7
METABOLIC ENZYME -> INDUCER
MULTIDRUG RESISTANCE PROTEIN 1
TRANSPORTER -> SUBSTRATE
CYTOCHROME P450 3A4
METABOLIC ENZYME -> INDUCER
Related Record Type Details
Structure of 6.ALPHA.-HYDROXYDEXAMETHASONE
METABOLITE -> PARENT
Structure of DEXAMETHASONE CIPECILATE
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
Structure of DESOXIMETASONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of DESOXIMETASONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 17,21-DIHYDROXY-16.ALPHA.-METHYLPREGNA-1,4-DIENE-3,11,20-TRIONE 21-PROPIONATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of BETAMETHASONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of DEXAMETHASONE SODIUM PHOSPHATE
PARENT -> IMPURITY
correction factor: for the calculation of content, multiply the peak area of impurity A by 0.75
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 17,21-DIHYDROXY-16.ALPHA.-METHYLPREGNA-1,4,7,9(11)-TETRAENE-3,20-DIONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of DEXAMETHASONE ACETATE ANHYDROUS
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of BETAMETHASONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of (16.ALPHA.)-17,21-DIHYDROXY-16-METHYLPREGNA-1,4-DIENE-3,11,20-TRIONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of DEXAMETHASONE ACETATE ANHYDROUS
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of 17,21-DIHYDROXY-16.ALPHA.-METHYLPREGNA-1,4,7,9(11)-TETRAENE-3,20-DIONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of DEXAMETHASONE SODIUM PHOSPHATE
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of (11.ALPHA.,16.ALPHA.)-9,11-EPOXY-17,21-DIHYDROXY-16-METHYLPREGNA-1,4-DIENE-3,20-DIONE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Structure of DEXAMETHASONE ACETATE ANHYDROUS
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Structure of VAMOROLONE ACETATE
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
Related Record Type Details
Structure of DEXAMETHASONE
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966